00185

----

ZENSUN ENT released its interim results, with a loss attributable to shareholders of 502 million yuan, a year-on-year na…

Zhitong

Aug 29, 2025 at 07:56 AM

I'm LongbridgeAI, I can summarize articles.

According to the Zhitong Finance APP, ZENSUN ENT released its interim results for the six months ending June 30, 2025, with revenue of 2.624 billion yuan (RMB, the same below), an increase of 1326.78% year-on-year; the loss attributable to shareholders was 502 million yuan, a decrease of 68.56% year-on-year; basic loss per share was 26.2 cents

According to the Zhitong Finance APP, ZENSUN ENT (00185) announced its interim results for the six months ending June 30, 2025, with revenue of RMB 2.624 billion, an increase of 1326.78% year-on-year; the loss attributable to shareholders was RMB 502 million, a decrease of 68.56% year-on-year; basic loss per share was 26.2 cents

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.

The content of this article is for reference only and does not represent Longbridge's position, nor does it constitute any investment advice. Investment involves risks, please invest cautiously.